Pharmiva is an innovation driven company with a focus on diseases related to women’s health. We develop and market products based on a unique expert knowledge within research and development of medical products aimed for local administration.

Major shareholders

Last update: 14 Dec 2020

GÅL Pharma Consulting10,0%
Indavvio AB9,8%
Venture Holdings AB6,0%
Prolajm AB4,9%
Nordnet Pensionsförsäkring4,8%
Quantify AB4,3%
TPJA Holding AB3,3%
CBC Holding AB3,2%
CBC Womens Health3,1%
Universal Energy AB2,4%
John Moll2,1%
Other investors (external shareholders)46,1%